Retina Associates of Michigan

Retina Associates of Michigan

Share

An ophthalmology practice specializing in the treatment of diseases of the retina and vitreous. They are board certified by the American Board of Ophthalmology.

We specialize in treating macular degeneration, diabetic retinopathy, retinal vascular occlusion, retinal detachment, macular holes, epiretinal membranes and other diseases of the retina, vitreous and macula. Our physicians are fully trained ophthalmologists with subspecialty fellowship training in diseases of the retina and vitreous.

09/07/2026

🇺🇸 Happy Labor Day!

Today we celebrate the hard work, dedication, and contributions of workers everywhere. At Retina Associates of Michigan, we are especially grateful for our incredible team who go above and beyond each day to care for our patients and protect the gift of sight. 👁️💙

Wishing you and your family a safe, restful, and enjoyable holiday!

09/05/2026

✨ Now Offering the Valeda Light Delivery System ✨

We’re excited to announce that Retina Associates of Michigan now offers the first and only FDA-authorized treatment for Dry Age-Related Macular Degeneration (AMD) proven to improve vision.

The Valeda Light Delivery System is a breakthrough, non-invasive therapy that uses multiwavelength photobiomodulation (PBM) to:
👁️ Improve visual acuity
⚡ Target mitochondrial dysfunction in the retina
🌟 Enhance patient outcomes for those with dry AMD

This advanced technology allows us to bring new hope to patients with dry AMD - offering treatment options where few have existed before.

📞 Call us today to learn if Valeda therapy is right for you.

09/03/2026

Electroretinography (ERG) measures how well the cells in your retina respond to light. It’s a powerful tool for diagnosing inherited retinal diseases, unexplained vision loss, and many complex conditions.

Understanding function helps us preserve vision.

09/01/2026

Thank you for the glowing review for Dr. Singh, Roxane! ⭐ ⭐ ⭐ ⭐ ⭐

08/31/2026

👨‍⚕️Doctor Spotlight!👨‍⚕️

Dr. Sophie brings extensive training, research, and surgical experience to Retina Associates of Michigan. After completing a research fellowship at Johns Hopkins University, he went on to complete his ophthalmology residency at the University of Louisville and a vitreoretinal fellowship at the Medical College of Wisconsin, performing more than 1,000 surgeries during his training.

With more than 35 published articles, Dr. Sophie continues to advance retinal care through research and serves as the Director of Clinical Research at Retina Associates of Michigan.

Outside of work, he enjoys traveling, spending time outdoors with his family, and watching and playing soccer.

We’re proud to have Dr. Sophie as part of the Retina Associates of Michigan team! 👁️

08/28/2026

🩸 Diabetes and Your Eyes
Diabetes can silently damage your retina. We offer specialized exams and treatments for diabetic retinopathy to keep your vision healthy. Early detection is key!

08/26/2026

Specialized retinal care starts with specialized training.

Retina Associates of Michigan is proud to have five highly trained physicians dedicated to the diagnosis, treatment, and surgical management of retinal and vitreous conditions:

𝗔𝗻𝗸𝘂𝗿 𝗡. 𝗠𝗲𝗵𝘁𝗮, 𝗠𝗗 — Board Certified, American Board of Ophthalmology
𝗖𝗵𝗿𝗶𝘀𝘁𝗼𝗽𝗵𝗲𝗿 𝗡. 𝗦𝗶𝗻𝗴𝗵, 𝗠𝗗, 𝗙𝗔𝗖𝗦 — Board Certified, American Board of Ophthalmology; Fellow, American College of Surgeons
𝗥𝗮𝗮𝗳𝗮𝘆 𝗦𝗼𝗽𝗵𝗶𝗲, 𝗠𝗗 — Board Certified, American Board of Ophthalmology; Director of Clinical Research
𝗧𝗮𝗿𝗲𝗸 𝗧𝗮𝗯𝗯𝗮𝗮, 𝗠𝗗 — Fellowship-trained vitreoretinal surgeon
𝗠𝗼𝗵𝗮𝗺𝗺𝗮𝗱 𝗔. 𝗦𝗮𝗯𝗯𝗮𝗴𝗵, 𝗠𝗗 — Fellowship-trained vitreoretinal specialist

Across the team, their backgrounds include advanced ophthalmology and vitreoretinal training at respected institutions throughout Michigan and across the country, along with experience in research, education, and complex retinal care.

Together, our five physicians bring their expertise to one shared goal: providing patients with advanced, specialized retinal care close to home.

08/24/2026

Idiopathic Juxtafoveal Telangiectasis (pronounced tell an gee ACT te sis) (JFT), also known as perifoveal telangiectasis or mac-tel for macular telangiectasia, is a condition in which abnormalities develop in blood vessels at the center of the retina. This central part of the retina, called the fovea, is responsible for the sharp vision needed for reading and recognizing faces.

SYMPTOMS
Patients with JFT may experience:
• Blurred vision
• Metamorphopsia (pronounced met a morf OP see ah) - a visual disturbance where straight lines appear wavy; parts of the central vision may also appear blank.
• Difficulty reading
• Visual field defects in one or both eyes

The condition may be diagnosed before it causes any symptoms at all.

Want your business to be the top-listed Gym/sports Facility in Grand Blanc?

Click here to claim your Sponsored Listing.

Location

Telephone

Address


8562 Holly Road
Grand Blanc, MI
48439

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm